Dermatologic Clinics 1994: Vol 12 Index

17 Pages·1994·3 MB·English

CUMULATIVE INDEX 1994
Volume 12
January USE OF THE LABORATORY IN DERMATOLOGY, pages 1-212
April CUTANEOUS LYMPHOMAS, pages 213-460
July OCCUPATIONAL DERMATOSES, pages 461-610
October CONTEMPORARY TROPICAL DERMATOLOGY, pages 611-840
Note: Page numbers for complete issues and articles are in boldface type.
Achromic nevus, vs. leprosy, in tropics, 639 prevention of, 504-505
Acne, occupational, airborne agents and, 501-502 Albinism, in tropics, 791-792
cutting fluids and, 539-540 laboratory diagnosis of, 94
Acquired immune deficiency syndrome. See AIDS. Aleukemic leukemia, clinical features of, 422
Acrodermatitis chronica atrophicans, in Lyme Alkali bums, industrial, 473
borreliosis, in tropics, 674-675 Allergic contact dermatitis, cytokines in, 287-288, 289
Acrylics, and allergic contact dermatitis, in dental in children, laboratory diagnosis of, 112
profession. See Dental profession. in dental profession. See Dental profession.
Actinic dermatitis, in tropics, 800 in pharmaceutical industry, 534-535
Actinic prurigo, in tropics, 798 Allergic dermatitis, occupational, cutting fluids and,
Acute disseminated miliary tuberculosis, in tropics, 647 541-542
Acute febrile neutrophilic dermatosis, clinical features of, Alpha-1-antitrypsin, in laboratory diagnosis, 191-192
423 Aluminum, and allergic contact dermatitis, in dental
Acute granulocytic leukemia, clinical features of, 420, profession, 526
424, 425, 426 Amebiasis, in tropics, genital manifestations of, 743
Acute irritant contact dermatitis, occupational, cliiucal American mucocutaneous leishmaniasis, in tropics, 703-
features of, 461-462 712
Acute myelogenous leukemia, clinical features of, 420, clinical features of, 703, 705
422, 424, 429 diagnosis of, 706
Acyclovir, for cutaneous lymphomas, 438 differential diagnosis of, 706-707
for genital herpesvirus infections, in tropics, 763 epidemiology of, 704-705
Adenoviruses, laboratory diagnosis of, 79 etiology of, 704
Adult T-cell leukemia/lymphoma, clinical features of, immunology of, 705-706
421, 425 pathology of, 703
Africa, eastern. See Eastern Africa. prevention of, 707-708
psoriasis in, 811-812 treatment of, 707-708
African histoplasmosis, clinical features of, 697-698 Amphotericin B, for American mucocutaneous
AIDS, in Eastern Africa, 624 leishmaniasis, in tropics, 707
in tropics, 747-752 Amyloid, laboratory diagnosis of, electron microscopy
clinical features of, 748-749 in, 143
histopathology of, 749-750 Amyloidosis, of nerves, vs. leprosy, in tropics, 641
laboratory diagnosis of, 749-750 Anderson-Fabry disease, laboratory diagnosis of, 96
transmission of, 747-748 Anesthesia, in laboratory diagnosis, of leishmaniasis, 39
treatment of, 750-751 Anesthetics, and allergic contact dermatitis, in dental
Kaposi's sarcoma in. See Kaposi’s sarcoma. profession, 527
Ainhum, in tropics, 787 local. See Local anesthetics.
Airborne occupational dermatoses, 501-509 Anetoderma, vs. granulomatous slack skin, 387
acne, 501-502 Angioedema, Cl esterase inhibitor and, 193-194
contact dermatitis, 502-508 Angiomatosis, bacillary, laboratory diagnosis of, 30, 31
allergens in, 505 Angiotensin converting enzyme, in laboratory diagnosis,
differential diagnosis of, 502-503 192-193
examples of, 503-504 Angola, psoriasis in, 812
investigation of, 505, 508 Antibiotics, for Lyme borreliosis, in tropics, 679-680
localization and symptoms of, 502 Antibodies, monoclonal. See Monoclonal antibodies.
825
826 CUMULATIVE INDEX 1994
Antibody capture, in laboratory diagnosis, of rubella, Bilharzides, in cutaneous schistosomiasis, in tropics,
72-73 714-715
Antigen capture enzyme immunoassay, in laboratory Biobrane, for industrial thermal bums, 470
diagnosis, of rubeola, 71 Biopsy, of mycosis fungoides, 315
Antigen detection, in laboratory diagnosis, of HIV of occupational chloracne, 571
infection, 79 skin. See Skin biopsy.
Antimalarial drugs, for lupus erythematosus, 203 Biotin metabolism, disorders of, in children, laboratory
Antimicrobials, and allergic contact dermatitis, in dental diagnosis of, 117-119
profession, 528 Bisphenol A/epichlorohydrin, and allergic contact
for industrial thermal bums, 470 dermatitis, in dental profession, 525
Antineutrophil cytoplasmic antibodies, in laboratory Blastomycosis, keloidal, in tropics, 698-699
diagnosis, of connective tissue diseases, 169-170 Blepharochalasis, vs. granulomatous slack skin, 387
Antinuclear antibodies, in laboratory diagnosis, of Blood pressure, assessment of, before major surgery,
connective tissue diseases. See Connective tissue 601-602
diseases. Blood transfusions, and AIDS, in tropics, 750
Antiphospholipid antibodies, in laboratory diagnosis, of and Lyme borreliosis, in tropics, 677
connective tissue diseases, 161-162 Bloom syndrome, laboratory diagnosis of, 93-94
with lupus erythematosus, 204-205 Bolivia, psoriasis in, 810
Arc bums, industrial, 471 Bone marrow transplantation, for cutaneous lymphomas,
Arms, elephantiasis of, in tropics, 723 438-439
Arterial disease, laboratory diagnosis of, 175-180 Borderline borderline leprosy, in tropics, 633, 637
ankle pressure in, 179 Borderline lepromatous leprosy, in tropics, 633, 637
continuous wave Doppler ultrasonography in, 175- Borderline tuberculoid leprosy, in tropics, 632-633, 637
177 Borrelia burgdorferi. See Lyme borreliosis.
digital plethysmography in, 180 Borreliosis. See Lyme borreliosis.
Doppler waveform analysis and pulsed volume Botflies, in myiasis, in tropics, 7'i2-73'5
recording in, 179-180 Boutonneuse fever, laboratory diagnosis of, 27
duplex ultrasonography in, 177 Brazil, psoriasis in, 810-811
plethysmography in, 1^ Brazilian pemphigus foliaceus. See Logo selvagem.
segmental pressures in, 179 Breasts, elephantiasis of, in tropics, 723
Arthritis, in Lyme borreliosis, in tropics, 676 Brucellosis, in Eastern Africa, 625
Ashy dermatosis, in tropics, 777-778 Bullous congenital ichthyosiform erythroderma,
Asia, psoriasis in, 813-814 laboratory diagnosis of, 101
Asphalt bums, industrial, 473-474 Bullous diseases, laboratory diagnosis of,
Aspirin, avoidance of, in hemostasis, 601 immunofluorescence in, 133-142
Ataxia-telangiectasia, laboratory diagnosis of, 93 bullous pemphigoid and epidermolysis bullosa
in children, 113-114 acquisita, 134-136
Athlete's foot, in tropics, 690 cicatricial pemphigoid, 136
Atopic dermatitis, in children, laboratory diagnosis of, direct, 134
109-110 indirect, 134
in Eastern Africa, 621 intraepidermal IgA neutrophilic dermatosis, 136,
Atopic individuals, patch testing of, for occupational 138
dermatoses, 491-499 lichen planus pemphigoides, 139-140
Australia, psoriasis in, 814 linear IgA bullous dermatosis, 139
Autologous bone marrow transplantation, for cutaneous lupus erythematosus, 140-141
lymphomas, 438-439 paraneoplastic pemphigoid, 138
Avidin-biotin method, in laboratory diagnosis, of Burns, industrial, 469-475
herpesvimses, 59 alkali, 473
Azathioprine, for lupus erythematosus, 203-204 cement, 473
chemical, 472-473
electrical, 471-472
hydrofluoric acid, 473
Bacillary angiomatosis, laboratory diagnosis of, 30, 31 molten metal, 470-471
Bacillary peliosis hepatis, laboratory diagnosis of, 30 phosphorus, 473
Bacterial infections, in children, laboratory diagnosis of, prevention of, 474
110 tar/asphalt, 473-474
Barrier creams, to prevent occupational irritant thermal, 469-470
dermatitis, 465-466 Burrow ink test, in laboratory diagnosis, of scabies, in
to prevent poison ivy and oak dermatitis, 514 children. 111
Bartonella. See Rickettsial diseases. Buruli ulcer, in tropics, 663
Bartonellosis, laboratory diagnosis of, 31-32 vs. cutaneous tuberculosis, 651
Basal cell carcinoma, in Eastern Africa, 622
Benign cephalic histiocytosis, laboratory diagnosis of,
electron microscopy in, 157
Benzocaine, and allergic contact dermatitis, in dental Cl esterase inhibitor, in laboratory diagnosis, 193-194
profession, 527 Calymmatobacterium granulomatis, in donovanosis, in
Benzoyl peroxide, and allergic contact dermatitis, in tropics, 759-760
dental profession, 525 in granuloma inguinale, 3-5
Bilharziasis cutanea tarda, in cutaneous schistosomiasis, Camphoroquinone, and allergic contact dermatitis, in
in tropics, 715-716 dental profession, 525
CUMULATIVE INDEX 1994 827
Cancer, occupational, cutting fluids and, 538 to naHve DNA, 163,165
of skin, in Eastern Africa, 622 to Ro and La, 165-167
Carcinoid syndrome, 5-hydroxyindoleacetic acid and, to small nuclear ribonuclear proteins, 165
196 antiphospholipid antibodies in, 161-162
Cardiac abnormalities, in Lyme borreliosis, in tropics, electron microscopy in. See Electron microscopy.
676 myositis-specific autoantibodies in, 168-169
Caribbean Islands, psoriasis in, 807, 810 Contact dermatitis, occupational, 477-484
Carmustine, for cutaneous lymphomas, 433-434 airborne agents and. See Airborne occupational
Carrion's disease, laboratory diagnosis of, 31 dermatoses.
Cellulose, oxidized, in hemostasis, 604 allergens in, classification of, 481-482
Cement bums, industrial, 473 clinical examination for, 478
Central America, psoriasis in, 807 clinical history of, 477
Central nervous system syphilis, laboratory diagnosis of, cutting fluids and, 540-541
11,15 guinea pig sensitization tests for, 480-482
Chanarin-Dorfman syndrome, laboratory diagnosis of, human repeat insult patch test for, 480-481
103-104 mouse ear swelling test for, 481
Chancroid, in tropics, clinical features of, 754-755 murine local lymph node assay for, 481
treatment of, 762 patch tests for, 479-480
laboratory diagnosis of, 1-3 provocative use test for, 480
Chediak-Higashi syndrome, laboratory diagnosis of, 94 quantitative structure achvity relationship in, 481
Chemical bums, industrial, 472-473 repeated open application test for, 480
Chemokines, in lymphoproliferative skin infiltrates, 284 time relationship in, 477-478
Chemotherapy, for AID^related Kaposi's sarcoma, 453- workplace visit by physician for, 478-479
454 Contact urticaria, in dental profession, 529-530
for cutaneous lymphomas, 433-434, 435, 436-437, 438 in pharmaceutical industry, 535
for leukemia cutis, 427-429 Copper, and allergic contact dermatitis, in dental
CHILD syndrome, laboratory diagnosis of, 102 profession, 526
Chlamydia, in tropics, 741-742 Corticosteroids, for fogo selvagem, in tropics, 774
Chlomydia trachomatis, in lymphogranuloma venereum, for lupus erythematosus, 202-203
5-6 Cotton swabs, in hemostasis, 602-603
Chloracne, occupational, 569-576 Coxiella burnetii. See Rickettsial diseases.
biopsy of, 571 Coxsackie A16 virus, in children, laboratory diagnosis
chemicals causing, 571-572 of. 111
clinical signs of, %9 cRNA-single-stranded conformational polymorphisms,
mechanism of, 574-575 to detect monoclonal lymphoid cell populations,
pentachlorophenol in, 572-573 346-347
treatment of, 572 Cryotherapy, for AIDS-related Kaposi's sarcoma, 452
Chondrodysplasia punctata, laboratory diagnosis of, 102 Cumulative irritant dermatitis, occupational, clinical
Chorionic villus sampling, in laboratory diagnosis, of features of, 462
chronic granulomatous disease, in children, 116 Curettage, definition of, 83-84
Chromomycosis, in tropics, 696-697 Cutaneous B-cell lymphomas, classification of, 214-215
vs. cutaneous tuberculosis, 651-652 dendritic cells in. See Dendritic cells.
Chronic granulocytic leukemia, clinical features of, 420, diagnosis of, monoclonal antibodies in, 223-225
422, 424, 426, 429 semimalignant. See Semimalignant cutaneous B-cell lym¬
Chronic granulomatous disease, in children, laboratory phomas.
diagnosis of, 115-116 Cutaneous larva migrans, in Eastern Africa, 622
Chronic lymphocytic leukemia, clinical features of, 420- Cutaneous lymphocytic infiltrates, dendritic cells in. See
422, 424-425, 426, 427, 429 Dendritic cells.
Chronic myelomonocytic leukemia, clinical features of, Cutaneous lymphomas, classification of, 213-217
422, 426 B-cell, 214-215
Cicatricial pemphigoid, laboratory diagnosis of, staging, 215
immunofluorescence in, 136 T-cell, 213-214
Circumcision, female, in Eastern Africa, 626 cytokines in. See Cytokines.
Collodion baby, laboratory diagnosis of, 101 diagnosis of, monoclonal antibodies in. See Monoclonal
Colombia, psoriasis in, 810 antibodies.
Colony-stimulating factors, in lymphoproliferative skin mantle-cell. See Mantle-cell lymphomas.
infiltrates, 285-286 treatment of, 433-441
Complement fixation test, in laboratory diagnosis, of stage-adapted, 433-439
cytomegalovirus, 75-76 stage la to I la, 433-435, 439
of herpesviruses, 61 stage Illb, 435-437, 439
of rubeola, 69 stage III/S6zary syndrome, 437-438, 439
Congenital erythropoietic porphyria, laboratory stage IVa and IVb, 438-439
diagnosis of, 94-95 Cutaneous schistosomiasis, in tropics, 713-717
Congenital heart disease, with lupus erythematosus, bilharziasis cutanea tarda, 715-716
laboratory diagnosis of, 167 bilharzides or schistosomides, 714-715
Connective tissue diseases, laboratory diagnosis of, 161- dermatitis schistosomica, 714
173 epidemiology of, 713
antineutrophil cytoplasmic antibodies in, 169-170 lesions related to complications, 716
antinuclear antibodies in, 162-168 pathology of, 713-714
in scleroderma, 167-168 treatment of, 716-717
828 CUMULATIVE INDEX 1994
Cutaneous T<ell lymphomas, classification of, 213-214 etiopathogenesis of, 645-646
clonal disease in, 351-360 treatment of, 652
immunohistochemistry of, 352, 354 vs. atypical mycobacteriosis, 650
molecular biology of, 354-355 vs. chromomycosis, 651-652
significance of, 355-358 vs. disseminated mycobacteriosis, 651
in inflammatory skin diseases, 358 vs. inoculation mycobacteriosis, 650-651
in mycosis fungoides and S^zary syndrome, 356- vs. nontuberculous scrofuloderma, 651
358 vs. sarcoidosis, 652
in pleomorphic T-cell lymphomas, 356 vs. sporotrichosis, 651
in skin diseases, 358 vs. tuberculoid leprosy, 651
cytogenetic findings in, 295-304 Cutis laxa, vs. granulomatous slack skin, 385-387
cell culture, phenotyping, and karyotyping in, 296 Cutis laxis elastofibrils, laboratory diagnosis of, electron
genotraumatic T-cell clones in, 297-301 microscopy in, 144
results of, 296-297 Cutting fluids, and occupational dermatoses, 537-546
cytokines in, 289-291 allergic dermatitis, 541-542
delta chain-positive. See Delta chain-positive cutaneous clinical patterns in, 542-544
T-cell lymphomas. chronic lichenified and fissured palmar eczema,
dendritic cells in. See Dendritic cells. 543-544
diagnosis of, molecular biology in. See Molecular biol¬ discoid eczema on forearms and hands, 544
ogy- erythematous papules on forearms and hands,
monoclonal antibodies in, 220-223 542-543
differential diagnosis of, 321 papulovesicles on hands and fingers, 543
early diagnosis of, 315-322 contact dermatitis, 540-541
biopsy in, 315 disorders of pigmentation, 538
controversies in, 329-334 folliculitis and oil acne, 539-540
activation- and proliferation-associated antigens, granulomas, 539
333 irritant dermatitis, 541
composition of cellular infiltrates, 329 keratoses and cancer, 538
majority T-cell antigen, 332-333 mechanical injuries, 538-539
pan-T-cell antigens and T-helper and -suppressor types of cutting fluids, 537-538
molecules, 329-330, 332 uses of cutting fluids, 537
T-cell antigen receptor, 332 Cyclosporin A, for cutaneous lymphomas, 438
tumor-cell-associated antigens, 333 Cystic fibrosis, in children, laboratory diagnosis of, 119
electron microscopy in, 317 Cytogenetics, of mantle-cell lymphomas, 414
histologic, 315-317 Cytokines, in lymphoproliferative skin infiltrates, 283-
immunohistochemistry in, 317 294
inter- and intrarater reliability of, 323-327 definition of, 283-286
materials and methods for, 323-324 chemokines, 284
results of, 324-325 colony-stimulating factors, 285-286
molecular biology in, 317 growth factors, 286
mycosis fungoides, 315-319 interferons, 286
pagetoid reticulosis, 319, 321 lymphocyte-stimulating factors, 284-285
S6zary syndrome, 319 multifunctional nonspecific mediators, 283-284
T-cell receptor gene rearrangement analysis in, 335- evidence for, 287
340 histologic features of, 287-288
evaluation of, inter- and intrarater variabilities in, 311- in cutaneous T-cell lymphomas, 289-291
314 pathophysiologic relevance of, 288-289
materials and methods for, 311 production of, by epidermal cells, 286-287
results of, 312 therapeutic, 291-292
laboratory diagnosis of, electron microscopy in, 149 Cytomegalovirus, laboratory diagnosis of, 75-77
monoclonal lymphoid cell populations in. ^e Mono¬
clonal lymphoid cell populations.
photoinactivated lymphocyte therapy for. See Photo-
inactivated lymphocyte therapy. Dactylolysis, in tropics, 787
retroviruses and. ^e Retroviruses. Dapsone, for lupus erythematosus, 204
thymus bypass model for, 305-310 Darier's disease, in tropics, 795
definition of, 307 Darkfield examination, in laboratory diagnosis, of
Cutaneous tuberculosis, in tropics, 645-655 syphilis, 12
clinical features of, 646-648 DDT, and occupational chloracne, 571
acute disseminated miliary tuberculosis, 647 Deep fungal infections, in tropics, 695-700
hypertrophic form, 648 African histoplasmosis, 697-698
lupus vulgaris, 647 chromomycosis, 696-697
plaque form, 647-648 keloidal blastomycosis, 698-699
scrofuloderma, 648 mycetoma, 695-696
tuberculosis cutis orificialis, 648 Delta chain-positive cutaneous T-cell lymphomas, 391-
tuberculosis verrucosa cutis, 648 397
tuberculous chancre, 647 case reports of, 391-395
ulcerative form, 648 clinical and histologic features in, 391-394
vegetative form, 648 immunophenotypic and genotypic features in, 394-
diagnosis of, 648-650 395
CUMULATIVE INDEX 1994 829
Denaturing gradient gel electrophoresis, to detect Donovanosis, in tropics, clinical features of, 759-760
monoclonal lymphoid cell populations, 346 treatment of, 763
Dendritic cells, in cutaneous B- and T-cell lymphomas, laboratory diagnosis of, 3-5
255-270 Drug-induced cutaneous eruptions, in leukemia, 424
anatomy, physiology, and distribution of, 255-256
B-cell lymphomas, 260-266
in normal and neoplastic tissue, 260-263
importance of, 256-257 Ear piercing, in Eastern Africa, 626
T-cell lymphomas, 257-260 Eastern Africa, dermatologic diseases in, 621-628
in cutaneous lymphocytic infiltrates, 271-282 AIDS, 624
and immunosurveillance, 271-273 atopic dermatitis, 621
Langerhans cells in, 272 brucellosis, 625
as antigen-presenting cells, 274-275 common superficial mycotic infections, 625
benign, 275-276 HIV infecHon, 624
characteristics of, 273-274 leprosy, 626
malignant, 276-280 measles, 624
Dental amalgam, and allergic contact dermatitis, 526 parasitic diseases, 622-623
Dental composite resins, and allergic contact dermatitis, rhinoscleroma, 621-622
520-521 scabies, 621
Dental profession, occupational dermatoses in, 517-532 self-inflicted or ritualistic injuries, 626
allergic contact dermatitis, 517, 520-529 skin cancer, 622
acrylic resin polymerization activators and tuberculosis, 624
inhibitors in, 525 yaws, 625-626
acrylics in, 517, 520-524 Eczema, photosensitive, in chronic actinic dermatitis, in
active sensitization by, 523 tropics, 800
for dental composite resins, 520-521 recalcitrant. See Recalcitrant eczema.
for dentin bonding compounds, 521-522 Ehlers-Danlos syndrome, laboratory diagnosis of, 96
for prostheses, 520 Ehrlichia. See Rickettsiai diseases.
glove penetration by, 522-523 Ehrlichiosis, laboratory diagnosis of, 29-30, 31
immediate hypersensitivity to, 524 Elastic fiber abnormalities, laboratory diagnosis of,
patch testing for, 523-524 electron microscopy in, 143-144,149
patient risk of, 523 Elastolysis with wrinkling, laboratory diagnosis of,
purity of, 523 electron microscopy in, 144
replacement of, 523 Elastosis perforans serpiginosa, laboratory diagnosis of,
antimicrobials in, 528 electron microscopy in, 144,149
epoxy resin compounds in, 524-525 Electrical bums, industrial, 471-472
fragrances in, 527-528 Electrocoagulation, in hemostasis, 602
Impregnum and Scutan in, 528-529 Electron microscopy, in laboratory diagnosis, 143-159
local anesthetics in, 527 of connective tissue diseases, 143-149
metals in, 525-527 amyloid, 143
resin carriers in, 528 elastic fiber abnormalities, 143-144,149
UV absorbers in, 528 of harlequin ichthyosis, 157-158
contact urticaria, 529-530 of herpesviruses, 56
screening series for, 530 of histiocytosis X, in children, 113
Dentin bonding compounds, and allergic contact of lymphohistiocytic disorders, 149, 153-157
dermatitis, 521-522 benign cephalic histiocytosis, 157
2'Deoxycoformicin, for cutaneous lymphomas, 438 cutaneous T-cell lymphoma, 149
Dermatitis, actinic, in tropics, 800 Langerhans cell histiocytosis, 149,153,157
atopic, in Eastern Africa, 621 of mycosis fungoides, 317
contact. See Contact dermatitis. Elephantiasis. See Filariasis.
in children, laboratory diagnosis of, allergic contact, Elliptic excision, definition of, 84
112 Endocrine disorders, with eczema, in children,
atopic, 109-110 laboratory diagnosis of, 117-119
nummular, 111-112 Enterovimses, laboratory diagnosis of, 79
seborrheic, 112 Enzyme immunoassay, in laboratory diagnosis, of
irritant. See Irritant dermatitis. cytomegalovims, 76
laboratory diagnosis of, with lupus erythematosus, 167 of Epstein-Barr virus, 77
WHO plan for, in tropics, 627-618 of erythema infectiosum, 75
Dermatitis schistosomica, in cutaneous schistosomiasis, of HIV infection, 78
in tropics, 714 of roseola, 74
Dermatophyte infections. See Superficial fungal infections. of rubella, 72
Dermatophytes, in children, laboratory diagnosis of. Ill Enzyme-linked immunosorbent assay, in laboratory
Dermatophytosis, in Eastern Africa, 625 diagnosis, of Lyme borreliosis, 21
Dermatosis, acute febrile neutrophilic, clinical features of mbeola, 70-71
of, 423 Epidemic typhus, laboratory diagnosis of, 28
N,N-Dimethyl-4-toluidine, and allergic contact Epidermolysis bullosa, in tropics, 794-795
dermatitis, in dental profession, 525 laboratory diagnosis of, 123-132
Discoid lupus erythematosus, vs. leprosy, in tropics, 640 acquired, 129-130
DNA probes, in laboratory diagnosis, of leishmaniasis, immunoelectron microscopy in, 129
46-47 immunoprecipitation and immunoblot in, 129-130
830 CUMULATIVE INDEX 1994
Epidermolysis bullosa (Continued) family Gasterophilidae, 732-733
indirect immunofluorescence in, 129 family Muscidae, 730
inherited, 123-129 family Oestridae, 733
immunofluorescence antigenic mapping in, 126- family Sarcophagidae, 732
127 genus Auchmeromyia, 732, 734
monoclonal antibody studies in, 127-128 genus Chrysomyia, 731-732
prenatal, 128 genus Cordylobia, 731
transmission electron microscopy in, 123-126 genus Cuterebridae, 732
Epidermolysis bullosa acquisita, laboratory diagnosis of, genus Dermatobia, 732
immunofluorescence in, 134-136 genus Hypoderma, 733
Epidermolytic hyperkeratosis, laboratory diagnosis of, genus Sarcophaga, 732
101 genus Wohlfahrtia, 732
Epididymitis, gonorrhea and, in tropics, 741 Fluorescent antibody microscopy, in laboratory
Epoxy acrylates, and allergic contact dermatitis, in diagnosis, of syphilis, 12
dental profession, 520-521 Fluorescent leprosy antibody absorption test, in
Epoxy resin compounds, and allergic contact dermatitis, laboratory diagnosis, of leprosy, in tropics, 638
in dental profession, 524-525 Fluorescent-treponemal-antibody absorption test, in
Epstein-Barr virus, laboratory diagnosis of, 77 laboratory diagnosis, of syphilis, 13
monoclonal antibodies in, 226-217 Fogo selvagem, in tropics, 765-776
Eruption of lymphocyte recovery, in leukemia, 424 antidesmosomal autoantibodies in, 769
Erythema chronicum migrans, in Lyme borreliosis, in clinical features of, 766-768, 766-769
tropics, 673 diagnosis of, 774
Erythema infectiosum, laboratory diagnosis of, 74-75 histopathology of, 769-770
Erythropoietic protoporphyria, laboratory diagnosis of, historical aspects of, 766
95 immunopathogenesis of, 770-774
N-Ethyl-4-toluene sulfonamide, and allergic contact epidemiologic factors in, 773-774
dermatitis, in dental profession, 528 immunogenetic factors in, 770
Eugenol, and allergic contact dermatitis, in dental immunologic factors in, 771-773
profession, 527-528 incidence of neonatal disease in, 768-769
Exanthem subitum, laboratory diagnosis of, 73-74 treatment of, 774
Excited skin syndrome, in patch tests, for occupational Folliculitis, occupational, cutting fluids and, 539-540
contact dermatitis, 480 Forearms, occupational dermatoses of, cutting fluids
Extracorporal photochemotherapy, for cutaneous and, 542-544
lymphomas, 435, 437, 438 Foundation for International Dermatologic Education,
Extracorporal photopheresis, for cutaneous lymphomas, tropical dermatology, 614
436 Fragrances, and allergic contact dermatitis, in dental
Eyes, changes in, in lupus erythematosus, 203 profession, 527-528
in Lyme borreliosis, in tropics, 676-677 Frictional dermatitis, in tropics, 779
industrial alkali bums of, 473 Fungal infections, deep. See Deep fungal infections.
superficial. See Superficial fungal infections.
Fabry disease, laboratory diagnosis of, 96
Fatty alcohol;NAD+ oxidoreductase, deficiency of, in Gambia, psoriasis in, 812
Sjogren-Larsson syndrome, 104 Gelfoam, in hemostasis, 604
Favus, in tropics, 688 Genital ulcer disease, in tropics, 753-764
Female circumcision, in Eastern Africa, 626 clinical features of, 754-760
Femoral vein, Doppler ultrasonography of, 183 chancroid, 754-755
Fibroma, recurrent infantile digital, laboratory diagnosis donovanosis, 759-760
of, electron microscopy in, 149 herpesvirus infections, 757-758
Filariasis, in tropics, 719-727 lymphogranuloma venereum, 758-759
definition of, 719 syphilis. 755-757
differential diagnosis of, 725 differential diagnosis of, 760-762
historical aspects of, 719-720 treatment of, 762-763
lymphatic, 721-723 Genitalia, elephantiasis of, in tropics, 722-723
diagnosis of, 724 Genodermatoses, in tropics, 787-796
epidemiology and etiology of, 721 ainhum and keloids, 787
pathogenesis of, 724 albinism, 791-792
social aspects of, 725 congenital ichthyoses, 790-791
treatment of, 724-725 hypomelanosis of Ito, 793-794
Fingers, occupational dermatoses of, cutting fluids and, neurofibromatosis, 793
543 palmoplantar keratoderma, 787-789
Fish fanciers' fingers, in tropics, 659-661 tuberous sclerosis, 793
vs. cutaneous tuberculosis, 650-651 xeroderma pigmentosum, 792
Fish tank granuloma, in tropics, 659-661 laboratory diagnosis of, 93-97
vs. cutaneous tuberculosis, 650-651 albinism, 94
Flash bums, industrial, 471 ataxia-telangiectasia, 93
Flies, in myiasis, 729. See also Myiasis. Bloom syndrome, 93-94
family Calliphoridae, 730-731 Chediak-Higashi syndrome, 94
family Cuterebridae, 732 Ehlers-Danlos syndrome, 96
CUMULATIVE INDEX 1994 831
Fabry disease, 96 Hemagglutination, in laboratory diagnosis, of
porphyria, 94-96 cytomegalovirus, 75
xeroderma pigmentosum, 94 Hemagglutination-inhibition, in laboratory diagnosis, of
German measles, laboratory diagnosis of, 72-73 rubella, 72
Gloves, and occupational dermatoses, 547-559 of rubeola, 69-70
natural rubber latex, 547-552 Hematomas, after cutaneous surgery, management of,
allergenicity of, 549-550, 552 606
chemical additives in, allergenicity of, 548-549 Hemostasis, hints for, 601-606
manufacture of, 547-548 anticipate large bleeders, 602
polyvinyl chloride, 555-557 avoid aspirin, 601
allergenicity of, 556-557 check blood pressure before major surgery, 601-602
manufacture of, 555-556 educate patients, 605-606
thermoplastic elastomers, 552-555 handle hematoma formation, 606
allergenicity of, 552-555 match hemostats with size of job, 605
manufacture of, 552 use cotton swabs, 602-603
penetration of, by acrylics, in dental profession, 522- use electrocoagulation to seal vessels, 602
523 use novel topical hemostatics, 603-605
to prevent occupational dermatoses, 597-600 Hepatoerythropoietic porphyria, laboratory diagnosis of,
ASTM permeation test for, 599 95-96
chemical and physical resistance requirements of, Hereditary coproporphyria, laboratory diagnosis of, 95
598-599 Heredopathia atactica polyneuritiformis, laboratory
cost of, 599-600 diagnosis of, 104
ergonomics of, 599 Herpes simplex virus, laboratory diagnosis of. See
evaluation of hazard in, 597-598 Herpesviruses.
from chemicals, 598 Herpesvirus infechons, in tropics, genital manifestations
need for, 597 of, 744, 757-758
selection of, 600 treatment of, 763
to prevent occupational irritant dermatitis, 465 Herpesviruses, clinical features of, 51-52
Glucagon, in laboratory diagnosis, 194-195 laboratory diagnosis of, 51-68
Glucagonoma syndrome, laboratory diagnosis of, 195- immunomorphologic tests in, 56-60
196 immunofluorescence techniques, 57-59
Glucantime, for American mucocutaneous leishmaniasis, immunoperoxidase techniques, 59-60
in tropics, 707 in children, 110-111
Glucocorticosteroids, for cutaneous lymphomas, 433 molecular virology in, 63-64
Glutaraldehyde, and allergic contact dermatitis, in dental polymerase chain reaction amplification, 64
profession, 528 morphologic tests in, 54-56
Gold, and allergic contact dermatitis, in dental biopsy, 55-56
profession, 526 electron microscopy, 56
Gonorrhea, in tropics, 740-741 Tzanck smear preparation, 54-55
Gram stain, in laboratory diagnosis, of chancroid, 1 serology in, 60-61
Granuloma inguinale, laboratory diagnosis of, 3-5 complement fixation test, 61
Granulomas, occupational, cutting fluids and, 539 neutralization test, 61
Granulomatous mycosis fungoides, and granulomatous specimen collection in, 52-53
slack skin, 387-388 specimen transport in, 54
Granulomatous slack skin, 375-389 virologic tests in, 61-63
as lymphoproliferative disease, 388 amplified culture techniques, 63
clinical features of, 376-378 antiviral drug addition, 63
differential diagnosis of, 385-388 confirmation and subtyping techniques, 62-63
histopathologic features of, 378-385 countercurrent immunoelectrophoresis, 63
historical aspects of, 375 cytopathic effect, 62
immunophenotypic and genotypic features of, 385 virus tissue culture, 61-62
treatment of, 388 Heterophile antibodies, in laboratory diagnosis, of
Growth factors, in lymphoproliferative skin infiltrates, Epstein-Barr virus, 77
286 Hexadecylphosphocholine, for cutaneous lymphomas,
Guillain-Barr^ type syndrome, in Lyme borreliosis, in 439
tropics, 675 Histamine, in laboratory diagnosis, 195-196
Guinea pig sensitization test, for occupational contact Histiocytic lymphoma, diagnosis of, monoclonal
dermatitis, 480 antibodies in, 226
Guinea worm infection, in tropics, genital manifestations Histiocytosis X, in children, laboratory diagnosis of, 113
of, 743 Histoid leprosy, in tropics, 634
diagnosis of, 637-638
Histoplasmosis, African, clinical features of, 697-698
HIV infection, in Eastern Africa, 624
Haemophilus ducreyi, in chancroid, 1-3 laboratory diagnosis of, 77-79
in tropics, 754-755 with syphilis, 11-12,15-16
Hairy cell leukemia, clinical features of, 421, 425 Hodgkin's disease, diagnosis of, monoclonal antibodies
Hands, occupational dermatoses of, cutting fluids and, in, 226
542-544 granulomatous slack skin and, 388
Harlequin ichthyosis, laboratory diagnosis of, electron Holocarboxylase synthetase deficiency, in children,
microscopy in, 157-158 laboratory diagnosis of, 117-118
832 CUMULATIVE INDEX 1994
Hong Kong, psoriasis in, 814 to diagnose CD30-positive large cell lymphomas, 364
Human immunodeficiency virus infection. See HIV to diagnose mycosis fungoides, 317
infection. to diagnose semimalignant cutaneous B-cell lympho¬
Human papillomavirus infection, in tropics, 743-744 mas, 402
Human repeat insult patch test, for occupational contact Immunoperoxidase techniques, in laboratory diagnosis,
dermatitis, 480-481 of herpesviruses, 59-60
Human T-cell lymphotropic virus. See Retroviruses. Immunophenotyping, of leukemia cutis, 425-427
Hydroa aestivale, in tropics, 798-799 Immunoprecipitation, in laboratory diagnosis, of
Hydroa vacciniforme, in tropics, 798-799 acquired epidermolysis bullosa, 129-130
Hydrofluoric acid bums, industrial, 473 Immunotherapy, for AIDS-related Kaposi's sarcoma, 454
Hydroquinone, and allergic contact dermatitis, in dental Impregnum, and allergic contact dermatitis, in dental
profession, 525 profession, 528-529
Hydroxychloroquine sulfate, for lupus erythematosus, Incontinentia pigmenti achromians, in tropics, 793-794
203 India, psoriasis in, 813
5-Hydroxyindoleacetic acid, in laboratory diagnosis, 196 Indian Leprologists' Association classification, of
2-Hydroxy-4-methoxy-benzophenone, and allergic leprosy, in tropics, 631
contact dermatitis, in dental profession, 528 Industrial hygienist, in occupational dermatoses, 591-
2-(2-Hydroxy-5-methylphenyl)benzotriazole, and 596
allergic contact dermatitis, in dental profession, 528 evaluations by, 591-592
Hyperimmunoglobulin E syndrome, in children, prospective, 594-595
laboratory diagnosis of, 116-117 retrospective, 593-594
Hypermelanosis, in tuberculosis, in Eastern Africa, 624 obtaining assistance from, 592-593
Hypertrophic interstitial neuritis, vs. leprosy, in tropics, workplace control of exposures by, 595-596
641 Infections, bacterial, in children, laboratory diagnosis of,
Hypomelanosis of Ito, in tropics, 793-794 110
Hypopigmentation, postinflammatory, vs. leprosy, in cutaneous, WHO plan for, in tropics, 617
tropics, 639 deep fungal. See Deep fungal infections.
mycobacterial. See Mycobacterial infections.
mycotic, in Eastern Africa, 625
superficial fungal. See Superficial fungal infections.
IBIDS syndrome, laboratory diagnosis of, 102-103 viral, in children, laboratory diagnosis of, 110-111
Ichthyosis, congenital, in tropics, 790-791 Inflammatory skin diseases, clonal disease in, 358
laboratory diagnosis of, 99-107 Interferons, for AIDS-related Kaposi's sarcoma, 454
bullous congenital ichthyosiform erythroderma, 101 for cutaneous lymphomas, 434-435,436, 437-438
CHILD syndrome, 102 for lupus erythematosus, 204
chondrodysplasia punctata, 102 for lymphoproliferative skin infiltrates, 291-292
classic lamellar ichthyosis, 100-101 in lymphoproliferative skin infiltrates, 286
harlequin, electron microscopy in, 157-158 Interleukin-1, in lymphoproliferative skin infiltrates,
IBIDS syndrome, 102-103 283- 284
ichthyosis vulgaris, 99-100 Interleukin-2, for cutaneous lymphomas, 438
in children, 113 in lymphoproliferative skin infiltrates, 284
in children, 120 Interleukin-4, in lymphoproliferative skin infiltrates,
KID syndrome, 103 284- 285
Netherton syndrom^, 103 lnterleukin-5, in lymphoproliferative skin infiltrates, 285
neutral lipicl storage disease, 103-104 Interleukin-6, in lymphoproliferative skin infiltrates, 284
nonbullous congenital ichthyosiform erythroderma, lnterleukin-7, in lymphoproliferative skin infiltrates, 285
100-101 Interleukin-9, in lymphoproliferative skin infiltrates, 285
recessive X-linked ichthyosis, 100 Interleukin-10, in lymphoproliferative skin infiltrates,
Refsum disease, 104 285
Sjogren-Larsson syndrome, 104 International League of Dermatological Societies, in
Immunoblot, in laboratory diagnosis, of acquired tropical dermatology, 612-616
epidermolysis bullosa, 129-130 International Society of Dermatology, in tropical
Immunocytochemistry, in leprosy, in tropics, 638 dermatology, 613-614
Immunoelectron microscopy, in laboratory diagnosis, of Intraepidermal IgA neutrophilic dermatosis, laboratory
acquired epidermolysis bullosa, 129 diagnosis of, immunofluorescence in, 136,138
Immunofluorescence, in laboratory diagnosis, of Intralesional therapy, for AIDS-related Kaposi's sarcoma,
acquired epidermolysis bullosa, 129 452-453
of bullous diseases and lupus erythematosus. See Irritant contact dermatitis, in pharmaceutical industry,
Bullous diseases. 534
of cytomegalovims, 76 occupational, clinical features of, 461-462
of Epstein-Barr vims, 77 Irritant dermatitis, occupational, 461-467
of herpesvimses, 57-59 clinical features of, 461-463
of HIV infection, 78 complications of, 463
of inherited epidermolysis bullosa, 126-127, 128 cutting fluids and, 541
of Lyme borreliosis, 21 diagnosis of, 464
of roseola, 74 disposition to, screening for, 466
of mbella, 72 epidemiology of, 463-464
of mbeola, 70 pathophysiology of, 461
Immunohistochemistry, to detect clonal disease, in prevention of, 465-466
cutaneous T<ell lymphomas, 352, 354 prognosis for, 465
CUMULATIVE INDEX 1994 833
risk factors for, 464 in Eastern Africa, 623
treatment of, 465 in tropics, genital manifestations of, 743
Isoenzyme analysis, in laboratory diagnosis, of laboratory diagnosis of, 37-50
leishmaniasis, 44 animal inoculation in, 42, 44
Isotretinoin, for lupus erythematosus, 204 approach to patient in, 38-40
Ixodes dammini, in Lyme borreliosis. See Lyme borreliosis. clinical features in, 38
comparison of methods in, 49
cultures in, 42
DNA probes in, 46-47
Kaposi's sarcoma, AIDS-related, treatment of, 451-456 epidemiology in, 38
chemotherapy in, 453-454 future trends in, 47-48
cryotherapy in, 452 histopathology in, 41-42
experimental, 454-455 isoenzyme analysis in, 44
immunotherapy in, 454 monoclonal antibodies in, 44-45
interferons in, 454 Montenegro or leishmanin skin test in, 46
intralesional, 452-453 serology in, 45-46
radiation therapy in, 452 smears in, 39-41
Keloidal blastomycosis, in tropics, 698-699 specimen handling in, 48
Keloids, in tropics, 787 Lepromatous leprosy, in tropics, 633-634
Kenya, psoriasis in, 811 diagnosis of, 637
Keratoses, occupational, cutting fluids and, 538 genital manifestations of, 743
KID syndrome, laboratory diagnosis of, 103 Lepronin test, in leprosy, in tropics, 638
Kuala Lumpur, psoriasis in, 813 Leprosy, in Eastern Africa, 626
in tropics, 629-644
classification of, 631
clinical features of, 631-635
Laboratory diagnosis, alpha-1-antitrypsin in, 191-192 borderline borderline, 633
angiotensin converting enzyme in, 192-193 borderline lepromatous, 633
Cl esterase inhibitor in, 193-194 borderline tuberculoid, 632-633
electron microscopy in. See Electron microscopy. histoid leprosy, 634
glucagon in, 194-195 in children, 635
histamine in, 195-196 indeterminate, 632
5-hydroxyindoleacetic acid in, 196 lepromatous leprosy, 633-634
immunofluorescence in. See Immunofluorescence. polyneuritic leprosy, 634-635
of arterial disease. See Arterial disease. tuberculoid tuberculoid, 632
of bullous diseases and lupus erythematosus. See Bul¬ diagnosis of, 636-639
lous diseases. histopathology in, 637-638
of chancroid, 1-3 immunocytochemistry in, 638
of cormective tissue diseases. See Connective tissue dis¬ lepromin test in, 638
eases. serology in, 638-639
of epidermolysis bullosa. See Epidermolysis bullosa. slit-skin smear in, 636-637
of genodermatoses. See Genodermatoses. epidemiology of, 629-630
of granuloma inguinale, 3-5 etiopathogenesis of, 630-631
of herpesviruses. See Herpesviruses. Lucio phenomenon in, 635-636
of ichthyosis. See Ichthyosis. reactions in, 635-636
of leishmaniasis. See Leishmaniasis. treatment of, 641-642
of Lyme borreliosis. See Lyme borreliosis. tuberculoid, vs. cutaneous tuberculosis, 651
of lymphogranuloma venereum, 5-6 vs. achromic nevus, 639
of morbilliform viral eruphons. See Morbilliform viral vs. discoid lupus erythematosus, 640
eruptions. vs. hypertrophic interstitial neuritis, 641
of recalcitrant eczema. See Reclacitrant eczema. vs. lupus vulgaris, 640
of rickettsial diseases. See Rickettsial diseases. vs. meralgia paresthetica, 641
of syphilis. See Syphilis. vs. myxedema, 641
of venous disease. See Venous disease. vs. neurofibromatosis, 641
skin biopsy in. See Skin biopsy. vs. nevus anemicus, 639
Lamellar ichthyosis, laboratory diagnosis of, 100-101 vs. peripheral neuritis, 641
Langerhans cell histiocytosis, laboratory diagnosis of, vs. pityriasis alba, 639
electron microscopy in, 149,153,157 vs. pityriasis rosea, 640
in children, 113 vs. pityriasis versicolor, 639-640
Langerhans cells, in dendritic cell system, in cutaneous vs. postinflammatory hypopigmentation, 639
lymphocyHc infiltrates, 272 vs. post-kala azar leishmaniasis, 640-641
Large perforators, Doppler ultrasonography of, 185 vs. primary amyloidosis of nerves, 641
Latex agglutination test, in laboratory diagnosis, of vs. psoriasis, 640
cytomegalovirus, 76-77 vs. tinea corporis, 640
of rubella, 73 vs. vitiligo, 639
Legs, elephantiasis of, in tropics, 722 Letterer-Siwe disease, laboratory diagnosis of, electron
Leiner syndrome, in children, laboratory diagnosis of, microscopy in, 153
117 in children, 113
Leishmaniasis, American mucocutaneous. See American Leukapheresis, for cutaneous lymphomas, 437, 438
mucocutaneous leishmaniasis. Leukemia cutis, 419-431
834 CUMULATIVE INDEX 1994
Leukemia cutis (Continued) Lyme borreliosis, in tropics, 669-685
clinical features of, 419-424 clinical features of, 673-677
nonspecific lesions, 422-424 cutaneous, 673-675
specific lesions, 419-422 extracutaneous, 675-677
histopathologic features of, 424-425 congenital, 677
immunophenotyping of, 425-427 course and prognosis of, 679
prognosis for, 427-429 diagnosis of, 677-678
treatment of, 427-429 differential diagnosis of, 678-679
Leukoderma, occupational, cutting fluids and, 538 ecology of, 671
Lichen planus pemphigoides, laboratory diagnosis of, epidemiology of, 669, 671
immunofluorescence in, 139-140 evolution of, 680
Lichen planus pigmentosus, in tropics, 778-779 historical aspects of, 669
Lidocaine, and allergic contact dermatitis, in dental in pregnancy, 677
profession, 527 microbiology of, 671-673
Light reflection rheography, in laboratory diagnosis, of prevention of, 679
venous disease, 185-186,189 transfusional risk in, 677
Linear IgA bullous dermatosis, laboratory diagnosis of, treatment of, 679-680
immunofluorescence in, 139 vaccination for, 680
Lip piercing, in Eastern Africa, 626 laboratory diagnosis of, 19-24
Lobomycosis, in tropics, 698-699 antibody response in, 20-21
Local anesthetics, and allergic contact dermatitis, in histopathology in, 20
dental profession, 527 microbiology in, 19-20
choosing system for, 817-823 polymerase chain reaction in, 21-22
agents in, 819-821 urine antigen testing in, 21
alkalinized lidocaine, 820 Lymphadenosis benigna cutis, in Lyme borreliosis, in
chloral hydrate, 820 tropics, 674
ice and EMLA, 819-820 Lymphangitis, in tropics, genital manifestations of, 743
lidocaine with or without epinephrine, 820 Lymphocyte-stimulating factors, in lymphoproliferative
pain attenuation by, 820-821
skin infiltrates, 284-285
saline with benzyl alcohol and epinephrine, 820 Lymphogranuloma venereum, in tropics, clinical
criteria for numbness in, 819
features of, 758-759
duration of anesthetic in, 818
treatment of, 763
for nonintact epidermis, 819
laboratory diagnosis of, 5-6
immediate availability in, 818
Lymphohistiocytic disorders, laboratory diagnosis of,
in adults with sensitive site, 821
electron microscopy in. See Electron microscopy.
in allergic patients, 822
Lymphomas. See Cutaneous B-cell lymphomas; Cutaneous
in average adults with minimal anxiety, 821-822
lymphomas; Cutaneous T-cell lymphomas.
in children with facial lesions, 821
primary cutaneous large cell. See Primary cutaneous
in nonanxious adults with nonsensitive site, 821
large cell lymphomas.
in nonanxious children with nonfacial lesions, 821
Lymphomatoid papulosis, vs. CD30-positive large cell
in severely frightened children, 821
lymphomas, 364-366
instantaneous anesthesia, 818
needle in, 819
patient factors in, 819
shelf life in, 818-819
Madrid classification, of leprosy, in tropics, 631
two-agent anesthesia, 819
Malassezia furfur, in pityriasis versicolor, in tropics, 779-
when anesthesia not usually given, 822
780
Low-molecular-weight chemicals, and contact urticaria,
Malaysia, psoriasis in, 813
in dental profession, 529-530
Lucio phenomenon, in leprosy, in tropics, 636 Mali, psoriasis in, 811-812
Lupus erythematosus, cutaneous lesions in, and cosmetic Mantle-cell lymphomas, 409-417
problems, 202 clinical features of, 409-413
ocular changes, 203 common findings in, 413
treatment of, 201-206 cytogenetics and molecular biology of, 414
anhmalarial drugs in, 203 of B-cell origin, 413-414
azathioprine in, 203-204 Mantoux test, in cutaneous tuberculosis, in tropics, 649
dapsone in, 204 Maple syrup urine disease, in children, laboratory
hydroxychloroquine sulfate in, 203 diagnosis of, 119
interferon in, 204 Mastocytosis, histamine and, 195-196
intralesional corticosteroids in, 203 Measles, in Eastern Africa, 624
isotretinoin in, 204 laboratory diagnosis of, 69-71
sunscreens in, 202 Mechlorethamine, for cutaneous lymphomas, 433-434,
topical corticosteroids in, 202-203 435, 437, 438
triamcinolone acetonide in, 203 Meglumine antimonate, for American mucocutaneous
with antiphospholipid antibodies, 204-205 leishmaniasis, in tropics, 707
with vasculitis, 204 Melanin deficiency syndrome, in tropics, 801
laboratory diagnosis of, 166-167 Melanoderma, occupational, cutting fluids and, 538
immunofluorescence in, 140-141 Melasma, in tropics, 781-782
Lupus vulgaris, in cutaneous tuberculosis, in tropics, 647 Meningitis, in Lyme borreliosis, in tropics, 675
vs. leprosy, in tropics, 640 Meralgia paresthetica, vs. leprosy, in tropics, 641